Literature DB >> 25388258

MicroRNA function in mast cell biology: protocols to characterize and modulate microRNA expression.

Steven Maltby1, Maximilian Plank, Catherine Ptaschinski, Joerg Mattes, Paul S Foster.   

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules that can modulate mRNA levels through RNA-induced silencing complex (RISC)-mediated degradation. Recognition of target mRNAs occurs through imperfect base pairing between an miRNA and its target, meaning that each miRNA can target a number of different mRNAs to modulate gene expression. miRNAs have been proposed as novel therapeutic targets and many studies are aimed at characterizing miRNA expression patterns and functions within a range of cell types. To date, limited research has focused on the function of miRNAs specifically in mast cells; however, this is an emerging field. In this chapter, we will briefly overview miRNA synthesis and function and the current understanding of miRNAs in hematopoietic development and immune function, emphasizing studies related to mast cell biology. The chapter will conclude with fundamental techniques used in miRNA studies, including RNA isolation, real-time PCR and microarray approaches for quantification of miRNA expression levels, and antagomir design to interfere with miRNA function.

Mesh:

Substances:

Year:  2015        PMID: 25388258     DOI: 10.1007/978-1-4939-1568-2_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

2.  Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.

Authors:  Yinghan Su; Bin Sun; Xuejing Lin; Xinying Zhao; Weidan Ji; Miaoxia He; Haihua Qian; Xianmin Song; Jianmin Yang; Jianmin Wang; Jie Chen
Journal:  Oncotarget       Date:  2016-08-02

3.  hsa‑miR‑429 targets CBX8 to promote cell apoptosis in diffuse large B‑cell lymphoma.

Authors:  Yan Liang; Zhuo-Jun Yu; Min Liu; Hui-Min Liu; Jiang-Zhao Zhang; Tao Xiong; Yuan-Yan Tang; Zhi-Ping Huang
Journal:  Mol Med Rep       Date:  2021-10-15       Impact factor: 2.952

4.  Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.

Authors:  Gift Dineo Pule; Shaheen Mowla; Nicolas Novitzky; Ambroise Wonkam
Journal:  Clin Transl Med       Date:  2016-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.